Stock A053030 BINEX CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials BINEX Co., Ltd.

Equities

A053030

KR7053030003

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 03:30:00 14/05/2024 am IST 		5-day change 1st Jan Change
15,660 KRW +11.22% Intraday chart for BINEX Co., Ltd. -2.12% +74.97%
15/03 BINEX Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
05/03 Singapore Stocks Linger in Red; IX Biopharma's Shares Soar 12% Following Unveiling of Novel Drug Delivery System MT

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 2,85,589 2,46,384 8,28,302 4,70,053 3,57,178 2,76,775
Enterprise Value (EV) 1 2,89,300 2,45,261 8,18,387 4,67,030 3,75,127 3,16,828
P/E ratio 44.9 x 29 x 129 x 24.8 x 28.7 x 82.6 x
Yield - - - - - -
Capitalization / Revenue 2.74 x 1.97 x 6.23 x 3.5 x 2.28 x 1.79 x
EV / Revenue 2.78 x 1.96 x 6.15 x 3.47 x 2.39 x 2.05 x
EV / EBITDA 18.3 x 12.1 x 37.5 x 25.1 x 14.7 x 29.1 x
EV / FCF 31.6 x -75.9 x 295 x 158 x -20.3 x -15.5 x
FCF Yield 3.17% -1.32% 0.34% 0.63% -4.93% -6.47%
Price to Book 1.91 x 1.54 x 4.78 x 2.61 x 1.86 x 1.53 x
Nbr of stocks (in thousands) 31,178 31,188 31,198 30,925 30,925 30,925
Reference price 2 9,160 7,900 26,550 15,200 11,550 8,950
Announcement Date 15/03/19 13/03/20 12/03/21 18/03/22 17/03/23 15/03/24
1KRW in Million2KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 1,04,043 1,25,259 1,32,976 1,34,399 1,56,677 1,54,825
EBITDA 1 15,833 20,337 21,817 18,617 25,480 10,872
EBIT 1 6,848 11,276 16,140 12,612 17,179 979.6
Operating Margin 6.58% 9% 12.14% 9.38% 10.96% 0.63%
Earnings before Tax (EBT) 1 4,797 10,619 6,205 24,234 15,234 4,895
Net income 1 6,337 8,504 6,412 19,094 12,445 4,671
Net margin 6.09% 6.79% 4.82% 14.21% 7.94% 3.02%
EPS 2 203.9 272.7 205.6 613.8 402.0 108.4
Free Cash Flow 1 9,160 -3,232 2,775 2,959 -18,487 -20,502
FCF margin 8.8% -2.58% 2.09% 2.2% -11.8% -13.24%
FCF Conversion (EBITDA) 57.85% - 12.72% 15.89% - -
FCF Conversion (Net income) 144.54% - 43.28% 15.5% - -
Dividend per Share - - - - - -
Announcement Date 15/03/19 13/03/20 12/03/21 18/03/22 17/03/23 15/03/24
1KRW in Million2KRW
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3
Net sales 1 33.41 39.77 35.31 40.36 39.53 41.48 48.2 39.5 31.6
EBITDA - - - - - - - - -
EBIT 1 3.336 5.935 2.595 8.136 6.19 0.4099 8.257 0.4194 -4.374
Operating Margin 9.99% 14.92% 7.35% 20.16% 15.66% 0.99% 17.13% 1.06% -13.84%
Earnings before Tax (EBT) 1 - 5.453 2.373 7.554 - -0.2469 8.732 2.22 -4.682
Net income 1 4.951 3.984 1.884 5.535 - -0.082 7.064 1.361 -5.498
Net margin 14.82% 10.02% 5.34% 13.72% - -0.2% 14.66% 3.44% -17.4%
EPS - - - - - - - - -
Dividend per Share - - - - - - - - -
Announcement Date 12/11/21 02/03/22 13/05/22 16/08/22 14/11/22 02/03/23 09/05/23 11/08/23 14/11/23
1KRW in Billions
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 3,711 - - - 17,949 40,053
Net Cash position 1 - 1,122 9,915 3,023 - -
Leverage (Debt/EBITDA) 0.2344 x - - - 0.7044 x 3.684 x
Free Cash Flow 1 9,160 -3,232 2,775 2,959 -18,487 -20,502
ROE (net income / shareholders' equity) 4.36% 5.34% 3.79% 10.7% 6.62% 2.45%
ROA (Net income/ Total Assets) 2.39% 3.58% 4.27% 2.91% 3.76% 0.22%
Assets 1 2,65,180 2,37,234 1,50,296 6,57,150 3,30,848 21,19,215
Book Value Per Share 2 4,793 5,146 5,552 5,834 6,196 5,863
Cash Flow per Share 2 421.0 593.0 1,621 1,620 1,007 264.0
Capex 1 2,545 8,791 7,698 11,850 25,933 7,747
Capex / Sales 2.45% 7.02% 5.79% 8.82% 16.55% 5%
Announcement Date 15/03/19 13/03/20 12/03/21 18/03/22 17/03/23 15/03/24
1KRW in Million2KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
BINEX CO., LTD. Stock BINEX Co., Ltd.
+74.97% 35Cr
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+31.06% 69TCr
NOVO NORDISK A/S Stock Novo Nordisk A/S
+30.35% 59TCr
JOHNSON & JOHNSON Stock Johnson & Johnson
-3.42% 36TCr
MERCK & CO., INC. Stock Merck & Co., Inc.
+18.02% 33TCr
ABBVIE INC. Stock AbbVie Inc.
+4.27% 29TCr
ASTRAZENECA PLC Stock AstraZeneca PLC
+15.53% 24TCr
NOVARTIS AG Stock Novartis AG
+10.16% 21TCr
ROCHE HOLDING AG Stock Roche Holding AG
-8.14% 20TCr
AMGEN INC. Stock Amgen Inc.
+8.12% 17TCr
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. A053030 Stock
  4. Financials BINEX Co., Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW